가축 유전학 시장 규모, 점유율 및 동향 분석 보고서 : 종별, 유전 물질별, 기술별, 최종사용자별, 지역별 및 부문별 예측(2026-2033년)

Livestock Genetics Market Summary

The global livestock genetics market size was valued at USD 7.8 billion in 2025 and is projected to grow from USD 8.4 billion in 2026 to USD 16.4 billion by 2033, at a CAGR of 10.0% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 32.2% in 2025. The market is primarily driven by key factors such as investment in bovine breeding programs across commercial dairy and beef operations; sovereign food-security spending driving the build-out of Gulf livestock genetics infrastructure; adoption of embryo transfer (ET) and IVF among elite breeding programs; and government-funded national breeding improvement and food-security investment programs.

Global Livestock Genetics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global livestock genetics market report based on species, genetic material, technology, end user, and region:

• Species Outlook (Revenue, USD Billion, 2021 - 2033)
• Bovine
• Ovine & Caprine
• Swine
• Poultry
• Other Species
• Genetic Material Outlook (Revenue, USD Billion, 2021 - 2033)
• Semen
• Embryos
• Live Breeding Animals
• Oocytes/Genetic Samples
• Technology Outlook (Revenue, USD Billion, 2021 - 2033)
• Artificial insemination (AI)
• Embryo Transfer (ET)
• IVF Technologies
• Other Technologies
• End User Outlook (Revenue, USD Billion, 2021 - 2033)
• Commercial Livestock Farms
• Breeding Centers
• Government Authorities
• Academic & Research Institutions
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Species
  • 1.2.2. Genetic Material
  • 1.2.3. Technology
  • 1.2.4. End User
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Top-Down Analysis
  • 1.7.3. Bottom-up Approach
  • 1.7.4. Multivariate Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Bovine Breeding Program Investment Across Commercial Dairy And Beef Operations
    • 3.2.1.2. Sovereign Food-Security Spending Driving Gulf Livestock Genetics Infrastructure Build-Out
    • 3.2.1.3. Embryo Transfer And IVF Adoption Among Elite Breeding Programs
    • 3.2.1.4. Government-Funded National Breeding Improvement And Food-Security Investment Programs
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited AI And ET Infrastructure Across Smallholder-Dominated Farming Systems
    • 3.2.2.2. High Capital And Technical Skill Requirements For IVF Adoption
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Technology Landscape
• 3.4. Pricing Analysis, 2025
• 3.5. Tariff Impact Analysis
• 3.6. Estimated Animal Population, By Key Countries & Key Species, 2021-2025
• 3.7. Market Analysis Tools
  • 3.7.1. Porter's Five Force Analysis
  • 3.7.2. PESTEL Analysis

Chapter 4. Livestock Genetics Market: Species Estimates & Trend Analysis

• 4.1. Livestock Genetics Market, By Species: Segment Dashboard
• 4.2. Livestock Genetics Market, By Species: Movement Analysis
• 4.3. Livestock Genetics Market Estimates & Forecasts, By Species, 2021 - 2033 (USD Billion)
• 4.4. Bovine
  • 4.4.1. Bovine Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.5. Ovine & Caprine
  • 4.5.1. Ovine & Caprine Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.6. Swine
  • 4.6.1. Swine Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.7. Poultry
  • 4.7.1. Poultry Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.8. Other Species
  • 4.8.1. Other Species Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Livestock Genetics Market: Genetic Material Estimates & Trend Analysis

• 5.1. Livestock Genetics Market, By Genetic Material: Segment Dashboard
• 5.2. Livestock Genetics Market, By Genetic Material: Movement Analysis
• 5.3. Livestock Genetics Market Estimates & Forecasts, By Genetic Material, 2021 - 2033 (USD Billion)
• 5.4. Semen
  • 5.4.1. Semen Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.5. Embryos
  • 5.5.1. Embryos Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.6. Live Breeding Animals
  • 5.6.1. Live Breeding Animals Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.7. Oocytes/Genetic Samples
  • 5.7.1. Oocytes/Genetic Samples Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Livestock Genetics Market: Technology Estimates & Trend Analysis

• 6.1. Livestock Genetics Market, By Technology: Segment Dashboard
• 6.2. Livestock Genetics Market, By Technology: Movement Analysis
• 6.3. Livestock Genetics Market Estimates & Forecasts, By Technology, 2021 - 2033 (USD Billion)
• 6.4. Artificial Insemination (AI)
  • 6.4.1. Artificial Insemination (AI) Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 6.5. IVF Technologies
  • 6.5.1. IVF Technologies Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 6.6. Embryo Transfer (ET)
  • 6.6.1. Embryo Transfer (ET) Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 6.7. Other Technologies
  • 6.7.1. Other Technologies Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Livestock Genetics Market: End User Estimates & Trend Analysis

• 7.1. Livestock Genetics Market, By End User: Segment Dashboard
• 7.2. Livestock Genetics Market, By End User: Movement Analysis
• 7.3. Livestock Genetics Market Estimates & Forecasts, By End User, 2021 - 2033 (USD Billion)
• 7.4. Commercial Livestock Farms
  • 7.4.1. Commercial Livestock Farms Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 7.5. Breeding Centers
  • 7.5.1. Breeding Centers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 7.6. Government Authorities
  • 7.6.1. Government Authorities Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 7.7. Academic & Research Institutions
  • 7.7.1. Academic & Research Institutions Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Livestock Genetics Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Dashboard
• 8.2. Regional Market Share Analysis, 2025 & 2033
• 8.3. North America
  • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.3.2. U.S
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 8.4. Europe
  • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 8.6. Latin America
  • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 8.7. MEA
  • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7.3. UAE
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7.4. Saudi Arabia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7.6. Qatar
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory Framework
    • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7.7. Oman
    • 8.7.7.1. Key Country Dynamics
    • 8.7.7.2. Competitive Scenario
    • 8.7.7.3. Regulatory Framework
    • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape

• 9.1. Key Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Market Assessment Analysis, 2025 (Heat Map Analysis)
• 9.3. Company Profiles
  • 9.3.1. Genus plc
    • 9.3.1.1. Company Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. STgenetics
    • 9.3.2.1. Company Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. URUS Group LP
    • 9.3.3.1. Company Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. SEMEX
    • 9.3.4.1. Company Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Select Sires Inc.
    • 9.3.5.1. Company Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. CRV
    • 9.3.6.1. Company Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. VikingGenetics
    • 9.3.7.1. Company Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Hendrix Genetics BV
    • 9.3.8.1. Company Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Topigs Norsvin
    • 9.3.9.1. Company Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Aviagen Group
    • 9.3.10.1. Company Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product Benchmarking
    • 9.3.10.4. Strategic Initiatives
  • 9.3.11. Cobb-Vantress, LLC
    • 9.3.11.1. Company Overview
    • 9.3.11.2. Financial Performance
    • 9.3.11.3. Product Benchmarking
    • 9.3.11.4. Strategic Initiatives
  • 9.3.12. EW Group
    • 9.3.12.1. Company Overview
    • 9.3.12.2. Financial Performance
    • 9.3.12.3. Product Benchmarking
    • 9.3.12.4. Strategic Initiatives
  • 9.3.13. MINITUB GMBH
    • 9.3.13.1. Company Overview
    • 9.3.13.2. Financial Performance
    • 9.3.13.3. Product Benchmarking
    • 9.3.13.4. Strategic Initiatives
  • 9.3.14. Neogen Corporation
    • 9.3.14.1. Company Overview
    • 9.3.14.2. Financial Performance
    • 9.3.14.3. Product Benchmarking
    • 9.3.14.4. Strategic Initiatives
  • 9.3.15. Zoetis
    • 9.3.15.1. Company Overview
    • 9.3.15.2. Financial Performance
    • 9.3.15.3. Product Benchmarking
    • 9.3.15.4. Strategic Initiatives